Shame on you Merck

Merck continues it’s stellar string of “achievements” by creating a fraudulent peer-review journal to publish data that casts a favorable light on Fosamax and other drugs. I’m not surprised at this course off action from Merck, a company that hasn’t had a blockbuster drug in years. I am more furious at Elsevier, a respected academic journal publisher, that did NOT exercise due diligence and placed their own integrity on the line for payola.

The question I always have when these scandals break is how many yesmen and yeswomen in both companies did it take to let this fly? Seriously who with commoncents thought this was a good idea.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s